vaccine technologies
vaccine technologies and types of vaccine treatments have been improving. This channel tracks news and blogs about advances in vaccine production, types of vaccines, and the companies that manufacture vaccines.
US - Vical has announced a breakthrough for pandemic influenza DNA vaccines following preliminary human data.
More perspectives...
From thepoultrysite.com
()
Vical Incorporated announced a breakthrough with preliminary clinical trial data demonstrating that DNA vaccines can safely achieve significant immune responses against H5N1 pandemic influenza in humans.
From news.search.yahoo.com via
Yahoo News.
()
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery ...
More perspectives...
From news.google.com via
Google News.
()
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced recently pre-clinical results from two proprietary plasmid DNA-based universal influenza vaccine candidates using the company's...
From news.search.yahoo.com via
Yahoo News.
()
- New DNA weapon against avian flu identified (thecheers.org)
- Animal Study Identifies New DNA Weapon Against Avian Flu (rss.topix.net)
Inovio Biomedical Corporation , a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced recently pre-clinical results from two proprietary ...
More perspectives...
From rss.topix.net via
Topix.
()
PORTLAND, Ore.----Bioject Medical Technologies Inc. , a leading developer of needle-free injection therapy systems, today announced that the Biojector® 2000 was used in Vical Inc.'s first Phase 1 human trial of H5N1 pandemic influenza DNA vaccines formulated with Vical's Vaxfectin® adjuvant...
More perspectives...
From news.search.yahoo.com via
Yahoo News.
()
SAN DIEGO----Inovio Biomedical Corporation , a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today that the Company has been invited to present at the following upcoming scientific conferences: Controlled Release...
More perspectives...
From news.search.yahoo.com via
Yahoo News.
()
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing phase I/II clinical study of its ChronVac-C® therapeutic DNA...
More perspectives...
From news.search.yahoo.com via
Yahoo News.
()






